Published in:
01-10-2021 | Guillain-Barré Syndrome | COVID-19
Post-acute sequelae of SARS-CoV-2 infection (PASC): peripheral, autonomic, and central nervous system features in a child
Author:
David S. Younger
Published in:
Neurological Sciences
|
Issue 10/2021
Login to get access
Excerpt
The 2019 novel coronavirus (2019‐nCoV [COVID-19]) epidemic is caused by the novel severe acute respiratory syndrome-coronavirus-2 (SARS-nCoV-2 or SARS-CoV-2). There are reviews of the acute neurological illness in adults [
1] and children [
2]. Recent attention has also been focused on the post-acute sequelae of SARS-CoV-2 infection (PASC) by the National Institutes of Health (NIH) through its launch of the Research Opportunity Announcement (ROA) OTA-21–0158, and the formation of the SARS-CoV-2 Recovery Cohort and Investigator Consortium (
https://covid19.nih.gov/sites/default/files/2021-02/PASC-ROA-OTA-Recovery-Cohort-Studies.pdf). The NIH operationally defines PASC as the failure to recover from acute COVID-19, or those persistently symptomatic for > 30 days from onset of infection, with any pattern of tissue injury that remains evolving including the nervous system. Online hosted surveys enrolling thousands of subjects employing mobile apps for symptom tracking to obtain real-world data and evidence provide useful information substantiating PASC in adults [
3] but exclude subjects < 18 years old. While awaiting prospective NIH-funded research, there is an urgency to understand PASC in children. …